As part of an effort to design human renin inhibitors with improved bioavailability, the amino-terminal Phe-His element present in many classes of renin inhibitors was replaced by a sulfone containing isostere.
Hydroxamic acid derivatives as proteinase inhibitors
申请人:British Biotech Pharmaceuticals
公开号:US06479502B1
公开(公告)日:2002-11-12
Compounds of formula (I) are matrix metalloprotemase inhibitors wherein X represents a carboxylic acid group —COOH, or a hydroxamic acid group —CONHOH;R2 represents a radical of formula (II): R3—(ALK)m—(Q)p—(ALK)n., and W represents a cyclic amino radical of formula (IIIA) or (IIIB):